![Hassan Javanbakht](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hassan Javanbakht
Hoofd Techniek/Wetenschap/O&O bij
MIRUM PHARMACEUTICALS, INC.
Profiel
Hassan Javanbakht is currently Chief Scientific Officer at Mirum Pharmaceuticals, Inc. Formerly, Chief Scientific Officer at Bluejay Therapeutics, Inc. Education includes a doctorate from McGill University.
Actieve functies van Hassan Javanbakht
| Bedrijven | Functie | Begin |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2026 |
Eerdere bekende functies van Hassan Javanbakht
| Bedrijven | Functie | Einde |
|---|---|---|
Bluejay Therapeutics, Inc.
 Bluejay Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics treatments for viral and liver diseases | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Hassan Javanbakht
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
22
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Bluejay Therapeutics, Inc.
Bluejay Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics treatments for viral and liver diseases | Health Technology |
